Petco Files 8-K for Regulation FD and Exhibit Disclosure

TL;DR

**Petco just filed a routine 8-K for disclosure, nothing major to see here.**

AI Summary

Petco Health & Wellness Company, Inc. filed an 8-K on February 26, 2024, to disclose information under Regulation FD and to include financial statements and exhibits. The filing indicates a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. This 8-K does not contain specific financial figures or major corporate actions like acquisitions or leadership changes, but rather serves as a general disclosure filing.

Why It Matters

This filing ensures Petco is compliant with SEC disclosure requirements, providing transparency to investors regarding any material non-public information that may have been shared.

Risk Assessment

Risk Level: low — This is a standard disclosure filing with no indication of adverse events or significant changes.

Key Players & Entities

• Petco Health & Wellness Company, Inc. (company) — Registrant
• February 26, 2024 (date) — Date of earliest event reported
• Delaware (company) — State of Incorporation
• 001-39878 (dollar_amount) — Commission File Number
• 81-1005932 (dollar_amount) — IRS Employer Identification No.

FAQ

Key Financial Figures

• $0.001 — tered Class A common stock, par value $0.001 per share WOOF The Nasdaq Stock Mar

Filing Documents

• woof-20240226.htm (8-K) — 38KB
• woof-ex99_1.htm (EX-99.1) — 7KB
• 0000950170-24-019763.txt ( ) — 155KB
• woof-20240226.xsd (EX-101.SCH) — 23KB
• woof-20240226_htm.xml (XML) — 4KB

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On February 26, 2024, Petco Health and Wellness Company, Inc. (the "Company") issued a press release announcing that Brian LaRose, Chief Financial Officer, will participate in the UBS Global Consumer and Retail Conference on March 14, 2024. Mr. LaRose will participate in a fireside conversation at approximately 11:00 a.m. Eastern Time. The full text of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1. The webcast of the event will be available via the Company's investor relations page at ir.petco.com. A replay of the webcast will be archived on the Company's investor relations page through March 28, 2024. The information being furnished pursuant to Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise be subject to the liability of that section, and shall not be incorporated by reference into any other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release, dated February 26, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Petco Health and Wellness Company, Inc. Date: February 26, 2024 By: /s/ Giovanni Insana Name: Giovanni Insana Title: Chief Legal Officer and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR